Clin Osteol 2025; 30(4): 210-215

Pain management in patients with osteoporosisReview articles

Jana Hrubešová1, Pavel Ryška2
1 Ambulance pro léčbu bolesti KARIM FN Hradec Králové
2 Radiologická klinika LF UK a FN Hradec Králové

Osteoporosis is characterized by the loss of bone mass, increased bone fragility, and a higher risk of fractures. It can remain asymptomatic for a long time, but once musculoskeletal changes develop, pain often occurs. Pain is one of the most distressing symptoms of osteoporosis and, if not properly managed, can significantly reduce a patient's quality of life and limit their functional abilities. Effective pain management should be an essential part of a comprehensive treatment plan for patients with this condition. When standard analgesic treatments are insufficient, minimally invasive techniques may be considered, offering rapid and effective pain relief when appropriately indicated.

Keywords: osteoporosis, chronic pain, pain management, opioids, cannabinoids, vertebroplasty.

Published: December 1, 2025  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Hrubešová J, Ryška P. Pain management in patients with osteoporosis. Clinical Osteology. 2025;30(4):210-215.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Purchase PDF - 50 CZK
    will be unlocked 1.12.2026

    References

    1. Kozák J, Lejčko J, Slíva J, et al. Metodické pokyny pro farmakoterapii chronické bolesti. Bolest Suppl. 2022;(1). [Internet]. Praha: TIGIS; 2022 [cited 2025 Dec 9]. Available from: https://www.tigis.cz/images/stories/Bolest/2022/Bolest_suppl_1_2022/pokyny_Bolest_suppl_1_2022.pdf
    2. Kozák J, Lejčko J, Vrba I, et al. Opioidy. Praha: Mladá fronta a.s.; 2018.
    3. Vrba I. Atypické opioidy. Bolest. 2024;27(1):616.
    4. Hakl M. Léčba chronické bolesti, atypické opioidy. Neurol Praxi. 2024;25(6):478481.
    5. Landa L, Juřica J, et al. Léčebné konopí v současné medicínské praxi. Praha: Grada Publishing; 2020.
    6. Chandra RV, Maingard J, Asadi H, et al. Vertebroplasty and kyphoplasty for osteoporotic vertebral fractures: what are the latest data? AJNR Am J Neuroradiol. 2018;39(5):798806.
    7. Wang B, Zheng Z, Chen H, et al. Balloon kyphoplasty versus percutaneous vertebroplasty for osteoporotic vertebral compression fracture: a metaanalysis and systematic review. J Orthop Surg Res. 2018;13:264.
    8. Ryška P, et al. Perkutánní vertebroplastika ve světě medicíny založené na důkazech. Čes Radiol. 2021;75(3):220227.
    9. Zhan Y, Jiang J, Liao H, et al. Risk factors for cement leakage after vertebroplasty or kyphoplasty: a metaanalysis of published evidence. World Neurosurg. 2017;101:633642.
    10. Firanescu C, de Vries J, Lodder P, et al. Vertebroplasty versus sham procedure for painful acute osteoporotic vertebral compression fractures (VERTOS IV): randomised doubleblind controlled clinical trial. BMJ. 2018;36:k1551.
    11. Clark WA, Bird P, Gonski P, et al. Safety and efficacy of vertebroplasty for acute painful osteoporotic fractures (VAPOUR): a multicentre, randomised, doubleblind, placebocontrolled trial. Lancet. 2016;388(10052):14081416.
    12. Halvachizadeh S, KaulGhanem R, Berk T, et al. Systematic review and metaanalysis of three treatment arms (vertebroplasty, kyphoplasty, conservative treatment) for osteoporotic vertebral fractures. JBJS Rev. 2021;9(10):e21.00064.
    13. Krüger A, Oberkircher L, Figiel J, et al. Minimalinvasive stabilization for osteoporotic vertebral fractures: cementless screw augmentation and less blood loss. Eur Spine J. 2010;19(12):21912198.
    14. Manchikanti L, Falco FJE, Benyamin RM, et al. An update of comprehensive evidencebased guidelines for interventional techniques in chronic spinal pain. Pain Physician. 2015;18(6):E535E582.

    Return to the content


    Clinical Osteology

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.